Title:
Research Network: Rare Diseases
Agreement Value:
$2,500,000.00
Agreement Date:
Oct 1, 2022 - Sep 30, 2027
Description:
This funding opportunity is designed to support a national network organized to:
• Identify instances where Canadian model organism expertise is relevant to a newly discovered disease gene. When such instances are found, a research project would be initiated to explore the functional characterization of the gene.
• Build on the established partnerships with programs developed in other regions/countries - modelled on the Canadian "Rare Diseases: Models & Mechanisms" Network – to:
1. support international partnerships when no compatible model can be identified in Canada; and
2. allow genes identified by clinicians in other countries to be studied by Canadian biomedical scientists.
• Enable the broadening of the modelling scope by supporting the entire scope of model systems available, including: new yeast models, animal models, patient derived tissue and organoid models.
• Catalyze new research efforts that target undeserved body systems, tissues, or diseases.
Organization:
Canadian Institutes of Health Research
Expected Results:
This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.
Location:
Vancouver, British Columbia, CA V6T 1Z1
Reference Number:
236-2022-2023-Q3-00486
Report Type:
Grants and Contributions
Recipient Type:
Individual or sole proprietorship
Recipient's Legal Name:
Hieter, Philip A
Research Organization:
University of British Columbia
Program:
Research in Priority Areas
Program Purpose:
This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.